Singlet oxygen-induced activation of Akt/protein kinase B is independent of growth factor receptors

Shougang Zhuang1, Irene E Kochevar

  • 1Wellman Laboratories of Photomedicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

Insights

Singlet oxygen (1O2) activates the Akt survival pathway via phosphatidylinositol-3-OH kinase (PI3-K) in fibroblasts, promoting cell survival. This differs from other oxidants as it bypasses growth factor receptors, FAK, and Ras protein.

Area of Science:

  • Cellular Biology
  • Oxidative Stress Research
  • Signaling Pathways

Background:

  • Singlet oxygen (1O2) induces cytotoxicity, implicated in photodynamic therapy and UV-A-induced apoptosis.
  • Other oxidants like hydrogen peroxide activate cell survival pathways, including Akt/protein kinase B, via growth factor receptors.

Purpose of the Study:

  • To investigate 1O2's ability to activate the Akt/protein kinase B pathway in NIH 3T3 cells.
  • To elucidate the specific pathways involved in 1O2-induced Akt activation.

Main Methods:

  • Exposure of NIH 3T3 fibroblasts to 1O2.
  • Assessment of Akt and p38 kinase phosphorylation.
  • Inhibition of phosphatidylinositol-3-OH kinase (PI3-K) and platelet-derived growth factor receptor (PDGFR).
  • Evaluation of focal adhesion kinase (FAK) and Ras protein activation.

Main Results:

  • 1O2 exposure caused sustained Akt phosphorylation alongside proapoptotic p38 kinase phosphorylation.
  • PI3-K inhibition blocked Akt phosphorylation and enhanced 1O2-induced cell death.
  • 1O2 did not activate PDGFR, SH-PTP2, FAK, or Ras protein.
  • Akt activation by 1O2 is PI3-K dependent and promotes fibroblast survival.

Conclusions:

  • Activation of the Akt survival pathway by 1O2 is mediated by PI3-K.
  • This PI3-K-Akt activation contributes to cell survival, counteracting 1O2-induced injury.
  • Unlike other oxidants, 1O2-induced Akt activation does not involve growth factor receptors, FAK, or Ras.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...